Artiva Biotherapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Artiva Biotherapeutics has a total shareholder equity of $201.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $225.6M and $24.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$146.63m |
| Equity | US$201.00m |
| Total liabilities | US$24.60m |
| Total assets | US$225.60m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: ARTV's short term assets ($150.6M) exceed its short term liabilities ($13.3M).
Long Term Liabilities: ARTV's short term assets ($150.6M) exceed its long term liabilities ($11.3M).
Debt to Equity History and Analysis
Debt Level: ARTV is debt free.
Reducing Debt: ARTV had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ARTV has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ARTV has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 32.3% each year.